"Astrocytin and malignin: Two Polypeptide Fragments (Recognins) Related to Brain Tumor"; National Cancer Institute Mon. 46:133-137, 1977.
"Disarmed Anti-Malignin Antibodies"; The Lancet 1:987, 1979.
"Monoclonal Anti-Malignin Antibodies"; The Lancet 2:141-142, 1981.
"Determination of Anti-Malignin Antibody and Malignin in 1,026 Cancer Patients and Controls: Relation of Antibody to Survival"; J. Medicine 13:49-69, 1982.
"Anti-Malignin Antibody and Scantag"; Protides Biol. Fluids 30:337-352, 1983.
"Elevated Levels of Anti-Malignin Antibody are Quantitatively Related to Longer Survival in Cancer Patients"; Protides Biol. Fluids 31:739-747, 1984.
"In Vitro Production of the General Transformation Antibody Related to Survival in Human Cancer Patients: Anti-Malignin Antibody (AMA)"; Cancer Detection and Prevention 18:Number 5/6, 551, 1985.
"Increased Accuracy of Anti-Malignin Antibody Determination in Unstored Sera Permits Screening"; Cancer Detection and Prevention 11:Number 1/2, 85, 1987.
"In Vitro Production of the General Transformation Antibody Related to Survival in Human Cancer Patients: Antimalignin Antibody"; Cancer Detection and Prevention 12:313-320,1988.
"Malignin antibody and early malignancy"(abstract below); The Lancet 337:977,1991.
"Malignin Antibody Returns to Normal After Successful Treatment of Breast Cancer"; Cancer Detection and Prevention 17(l):180,1993.
"Malignin Antibody As Early Warning"; Cancer Detection and Prevention 17(l): 229,1993.
"Comparison of Antimalignin With Other Markers for Early Detection and Surrogate Endpoint Use in Chemoprevention Trials for Breast, Colon, and Prostate Cancer"' J. Cell Biochem. 19:61,1994 (National Cancer Institute Symposium).
"Early Detection and Monitoring of Cancer with the Anti-Malignin Antibody Test" ; Cancer Detection and Prevention: 18(l):65-78,1994.
"A Checklist for Suitability of Biomarkers as Surrogate Endpoints in Chemoprevention of Breast Cancer" (abstract below) ; J. Cell. Biochem 19:172-185,1994 (National Cancer Institute Symposium).
"Aglyco Pathology of Viral Receptors in Dementias. In Functional Diversity of Interacting Receptors"; New York Academy of Sciences 757:413-417,1995.
"Return of Elevated Antimalignin Antibody to Normal Indicates Remission of Breast Cancer"; American Association for Cancer Research 37:486,1996.
"Antimalignin Antibody (AMASŪ) Elevation Detects Persistent or Recurrent Breast Cancer"; Cancer Detection and Prevention 20(5):508-509,1996.
"A New Era for Cancer Diagnosis and Treatment Based Upon Earlier, Asymptomatic, Detection"; J. Adv. Med. 10:149-150,1997.
"Production of a Synthetic General Cancer Vaccine Which Augments the Concentration of Antimalignin Antibody In Vivo" ; Cancer Detection and Prevention 22(l):S-227,1998.
"A Quantitative Immune Response in Human Cancer" ; Cancer Detection and Prevention 22(l):S-159,1998.
Source: www.oncolabinc.com Posted 10/06 after Ann Fonfa met S. Winston Bogoch, MD, Chief Operating Officer of Oncolab, Inc. at ASCO (meeting of the American Society for Clinical Oncology), 2006.
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.